Important Triad in Cardiovascular Medicine

This publication has 25 references indexed in Scilit:

• Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial)
  The American Journal of Cardiology, 2002
• Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization
  New England Journal of Medicine, 2001
• The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation
  Journal of the American College of Cardiology, 1998
• Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
  New England Journal of Medicine, 1997
• Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
  New England Journal of Medicine, 1996
• Mortality and Morbidity in Diabetic and Nondiabetic Patients During a 2-Year Period After Coronary Artery Bypass Grafting
  Diabetes Care, 1996
• Potential mechanisms promoting restenosis in diabetic patients
  Journal of the American College of Cardiology, 1996
• The Activated Megakaryocyte-Platelet-System Vascular Disease: Focus on Diabetes
  Seminars in Thrombosis and Hemostasis, 1995
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
  The Lancet, 1994
• Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
  New England Journal of Medicine, 1994